Development and validation of machine learning-based prediction model for outcome of cardiac arrest in intensive care units.

Journal: Scientific reports
PMID:

Abstract

Cardiac arrest (CA) poses a significant global health challenge and often results in poor prognosis. We developed an interpretable and applicable machine learning (ML) model for predicting in-hospital mortality of CA patients who survived more than 72 h. A total of 721 patients were extracted from the Medical Information Mart for Intensive Care IV database, divided into the training set (n = 576) and the internal validation set (n = 145). The external validation set containing 856 cases were collected from four tertiary hospitals in Zhejiang Province. The primary outcome was in-hospital mortality. Eleven ML algorithms were utilized to establish prediction models based on data from 72 h after return of spontaneous circulation (ROSC). The results indicate that the CatBoost model exhibited the best performance at 72 h. Eleven variables were ultimately selected as key features by recursive feature elimination (RFE) to construct a compact model. The final model achieved the highest AUC of 0.86 (0.80, 0.92) in the internal validation and 0.76 (0.73, 0.79) in the external validation. SHAP summary plots and force plots visually explained the predicted outcomes. In conclusion, 72-h CatBoost showed promising performance in predicting in-hospital mortality of CA patients who survived more than 72 h. The model still requires further optimization and improvement.

Authors

  • Peifeng Ni
    Zhejiang University School of Medicine, Zhejiang, 310006, Hangzhou, China.
  • Sheng Zhang
    Department of Critical Care Medicine, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Taizhou, China.
  • Gensheng Zhang
    Department of Critical Care Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou, 310000, China.
  • Weidong Zhang
    Department of Automation, Shanghai Jiaotong University, Shanghai 200240, China. Electronic address: wdzhang@sjtu.edu.cn.
  • Hongwei Zhang
    Jiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, China Pharmaceutical University, Nanjing, Jiangsu 211198, China.
  • Ying Zhu
    China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China.
  • Wei Hu
    State Key Laboratory for Novel Software Technology, Nanjing University, Nanjing, China.
  • Mengyuan Diao
    Fourth Clinical Medical College of Zhejiang Chinese Medical University, Zhejiang, 310006, Hangzhou, China. diaomengyuan@hospital.westlake.edu.cn.